Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04222491 · ClinicalTrials.gov registry record
Food Oral Immunotherapy for Peanut Allergy
A clinical trial, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- 500
- Enrollment target
NCT04222491: Active study, sponsored by Massachusetts General Hospital.
NCT04222491 is a clinical trial that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04222491 is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
Study Summary
This is an open label observational single center study of clinical food oral immunotherapy outcomes with biomarker samples and participant and/or caregiver-completed questionnaires in participants between 6 months and 65 years of age with IgE-mediated peanut allergy undergoing food oral immunotherapy.
Interventions
- DRUG Peanut oral immunotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-06-25 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04222491
The ClinicalTrials.gov registry entry for NCT04222491 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peanut oral immunotherapy is the first listed.
NCT04222491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04222491 about?
NCT04222491 is a clinical study titled "Food Oral Immunotherapy for Peanut Allergy". This is an open label observational single center study of clinical food oral immunotherapy outcomes with biomarker samples and participant and/or caregiver-completed questionnaires in participants between 6 months and 65 years of age with IgE-mediated peanut allergy undergoing food oral immunothera...
What is the current status of trial NCT04222491?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2020-06-25. Estimated completion is 2026-12.
What interventions are being tested in trial NCT04222491?
The interventions under investigation include: Peanut oral immunotherapy (DRUG).
Who is sponsoring clinical trial NCT04222491?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.